Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.46 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.37 |
| ▸ | CES2 | O00748 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL11295484 | 0.98 | FDPS (0.45) | FDPSSMPD1CES1CES2ALDH1A1 | |
| SCHEMBL27916871 | 0.93 | FDPS (0.48) | FDPSSMPD1CES2 | |
| SCHEMBL9067900 | 0.82 | FDPS (0.48) | FDPSSMPD1CES1CES2 | |
| SCHEMBL29194351 | 0.80 | FFAR1 (0.53) | FDPS | |
| SCHEMBL28912308 | 0.80 | FDPS (0.42) | FDPSSMPD1CES2 | |
| SCHEMBL288685 | 0.80 | FDPS (0.46) | FDPSSMPD1ALDH1A1MEN1CYP1A2 | |
| SCHEMBL7259933 | 0.80 | FDPS (0.46) | FDPSSMPD1CES1CES2MEN1 | |
| SCHEMBL29194354 | 0.79 | FFAR1 (0.51) | FDPSSMPD1 | |
| SCHEMBL22617790 | 0.78 | FDPS (0.45) | FDPSSMPD1CES1CES2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28391923 | 0.78 | FDPS (0.45) | FDPSSMPD1ALDH1A1MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084681-A | Method for extracting pentanediamine from pentanediamine catalytic liquid | 湖北三宁碳磷基新材料产业技术研究院有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-109942437-B | Method for separating and purifying pentamethylene diamine | 南京工业大学 | 2021-02-12 | — | — | CN | disclosed |
| CN-103492553-B | For producing the method for cadaverine and recombinant microorganism | 巴斯夫欧洲公司 | 2018-06-12 | — | — | CN | disclosed |
| US-8906653-B2 | Method for fermentatively producing 1,5-diaminopentane | BASF SE (DE) | 2014-12-09 | — | — | US | disclosed |
| US-8785695-B2 | Method for purifying compounds containing amino groups | BASF SE (DE) | 2014-07-22 | — | — | US | disclosed |
| CN-101981202-B | Method for producing 1, 5-diaminopentane by fermentation | BASF SE | 2013-09-11 | — | — | CN | disclosed |
| EP-2513039-A1 | METHOD FOR PURIFYING COMPOUNDS COMPRISING AMINO GROUPS | BASF SE (DE) | 2012-10-24 | — | — | EP | disclosed |
| US-20120253076-A1 | METHOD FOR PURIFYING COMPOUNDS CONTAINING AMINO GROUPS | BASF SE (DE) | 2012-10-04 | — | — | US | disclosed |
| WO-2012114256-A1 | PROCESSES AND RECOMBINANT MICROORGANISMS FOR THE PRODUCTION OF CADAVERINE | BASF SE (DE) | 2012-08-30 | — | — | WO | disclosed |
| EP-2235194-B1 | Method for fermentatively producing 1,5-diaminopentane | BASF SE (DE) | 2011-07-20 | — | — | EP | disclosed |
| WO-2011082976-A1 | METHOD FOR PURIFYING COMPOUNDS COMPRISING AMINO GROUPS | BASF SE (DE) | 2011-07-14 | — | — | WO | disclosed |
| CN-101981202-A | Method for producing 1, 5-diaminopentane by fermentation | BASF SE | 2011-02-23 | — | — | CN | disclosed |
| US-20100292429-A1 | Method for Fermentatively Producing 1,5-Diaminopentane | BASF SE (DE) | 2010-11-18 | — | — | US | disclosed |
| EP-2235194-A2 | METHOD FOR FERMENTATIVELY PRODUCING 1,5-DIAMINOPENTANE | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009092793-A2 | METHOD FOR FERMENTATIVELY PRODUCING 1,5-DIAMINOPENTANE | BASF SE (DE) | 2009-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120253076-A1 | METHOD FOR PURIFYING COMPOUNDS CONTAINING AMINO GROUPS | AADAT, BCAT2, BCAT1 | FDPS 2657/4885SMPD1 4527/4885CES1 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.